• Intermittent Hypoxia Training and Adaptogens with Karim Chubin

  • Sep 21 2024
  • Durée : 1 h et 16 min
  • Podcast

Intermittent Hypoxia Training and Adaptogens with Karim Chubin

  • Résumé

  • In this episode, Teemu Arina meets Karim Chubin to discuss Intermittent Hypoxia Hyperoxia Therapy (IHHT) as well as various adaptogens and their effects.

    Karim Chubin is a British-trained anthropologist, Swiss and German-certified naturopath, and visionary entrepreneur. Since 2004, he has led a groundbreaking clinical practice that integrates declassified Siberian (Russian) naturopathic innovations with his unique gifts as a clairvoyant and naturopathic medium. Karim's boutique practice, headquartered in Geneva with satellite offices in Brussels and Moscow, specializes in sleep harmonization, regenerative medicine, and personalized lifestyle wellness. His work focuses on enhancing mitochondrial and vibrational health from a vitalistic perspective, with the goal of optimizing longevity and overall well-being.

    Fluent in several languages, Karim is a health rebel and global traveller dedicated to bridging the gap between Eastern and Western medical wisdom. He is the founder of karimchubin.com and the Karim Chubin podcast, where he shares cutting-edge health discoveries with a worldwide audience. Currently, Karim is spearheading the "Million Minds Mission", aimed at educating one million people on transforming their lives through a new health paradigm that merges mitochondrial and vibrational medicine. His innovative approach to wellness is also embodied in "Loungevity," a 360-degree mind-body immersion experience designed to foster deep, sustainable regeneration.

    This conversation was recorded in September 2024.


    Visit https://www.karimchubin.com and follow @karimchubin on TikTok to learn more!


    Check https://biohackersummit.com for upcoming events & tickets!


    Devices, supplements, guides, books & quality online courses for supporting your health & performance: https://biohackercenter.com


    Key moments and takeaways:


    00:00 Introduction by Teemu Arina

    01:54 Karim's background

    04:00 Discovering IHHT

    07:04 How IHHT works technically

    08:23 How things worked before Big Pharma

    09:48 IHHT versus HBOT

    12:33 The challenge is educating people

    14:15 Enhancing mitochondrial functions

    16:59 Various benefits of IHHT

    18:41 Binding IHHT with different health modalities

    20:00 Overstimulation has a negative effect

    24:29 The Million Minds mission

    27:22 Wim Hof method versus IHHT

    30:45 Hypoxic states

    33:53 The most common adaptogens

    37:51 Discovering adaptogens

    39:13 Plants which brave Siberian winters

    42:00 Shifting appetites

    45:09 Adaptogens speak straight to the head

    46:25 Do we regard aging as a disease?

    48:41 Cellular surprise

    50:40 About some lesser known adaptogens

    52:24 Maral Root vs. microcirculation

    55:07 We borrow from the plant kingdom to find our center

    56:52 Bacopa Monieri

    58:00 Sagan Dalya (Rhododendron Adamsii)

    63:24 Blue Lotus is not exactly an adaptogen, but has interesting properties

    66:09 Kudzu works against various types of addictions

    67:46 TUR devices such as CellOxy or CellAirOne

    69:43 Disclaimer about Karim's relationship with TUR

    71:48 The importance of ethics at the beginning and end of the chain

    74:34 Karim's Loungevity brand

    Afficher plus Afficher moins
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !

    Ce que les auditeurs disent de Intermittent Hypoxia Training and Adaptogens with Karim Chubin

    Moyenne des évaluations utilisateurs. Seuls les utilisateurs ayant écouté le titre peuvent laisser une évaluation.

    Commentaires - Veuillez sélectionner les onglets ci-dessous pour changer la provenance des commentaires.

    Il n'y a pas encore de critique disponible pour ce titre.